FDA Clears New Blood Test that Could Speed Alzheimer’s Diagnosis and Treatment

Health & LifestyleNews
150

Listen to article (english)

Translate to Spanish or other 102 languages!

With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes
With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes

Mega Doctor News

- Advertisement -

By George Washington University

Newswise – With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed.

This week, the FDA cleared Roche’s Elecsys pTau181 test — only the second blood-based biomarker test approved this year for Alzheimer’s disease. The test, developed with Eli Lilly, gives primary care physicians a faster way to help rule out Alzheimer’s in patients showing signs of cognitive decline, potentially reducing reliance on costly PET scans and getting patients to answers — and treatment — sooner.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
HHSC Encourages Preventive Care During Breast Cancer Awareness Month
Next article
STHS Children’s Partners with Spirit Halloween for Pre-Halloween Party for Patients

More Articles

How to Keep Your Thanksgiving Dinner Safe

As families across the country prepare for Thanksgiving, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is reminding consumers to take simple steps that will keep their holiday meals safe and enjoyable.

Op-ED: More than a ‘Smokers Disease’: Why Lung Cancer Awareness Must Become a Priority

In the wake of Pope Leo XIV’s recent lung cancer diagnosis, public interest in the disease has surged, underscoring the important role prevention and early detection play in achieving better outcomes.

How Friday the 13th Became the Most Feared Date on the Calendar

Today is Friday, but not everyone is celebrating the end of the workweek this time around. That’s because of superstition surrounding Friday the 13th.

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.
- Advertisement -